[Present status of studies on antileprosy drugs].
Gidoh
M
M
National Institute for Leprosy Research, Tokyo, Japan.
Saito
H
H
D000818:Animals; D017291:Clarithromycin; D003622:Dapsone; D004359:Drug Therapy, Combination; D006801:Humans; D007155:Immunologic Factors; D007917:Leprostatic Agents; D008911:Minocycline; D011515:Prothionamide; D015363:Quinolones; D012293:Rifampin; D012294:Rifamycins; D013792:Thalidomide
D007155:Immunologic Factors; D007917:Leprostatic Agents; D015363:Quinolones; D012294:Rifamycins; C068980:KRM 1648; D013792:Thalidomide; D011515:Prothionamide; D003622:Dapsone; D008911:Minocycline; D017291:Clarithromycin; D012293:Rifampin